These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1659 related articles for article (PubMed ID: 20334633)

  • 21. Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration.
    Boutron I; Moher D; Altman DG; Schulz KF; Ravaud P;
    Ann Intern Med; 2008 Feb; 148(4):295-309. PubMed ID: 18283207
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improving the quality of reports of randomised controlled trials: the CONSORT statement.
    Otwombe KN; Ogutu B
    East Afr Med J; 2002 Jul; 79(7):394-6. PubMed ID: 12638837
    [No Abstract]   [Full Text] [Related]  

  • 23. [The CONSORT statement for cluster randomised trials].
    Campbell MK; Elbourne DR; Altman DG;
    Med Clin (Barc); 2005 Dec; 125 Suppl 1():28-31. PubMed ID: 16464424
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Consolidated Standards of Reporting Trials (CONSORT) extensions covered most types of randomized controlled trials, but the potential workload for authors was high.
    Ghosn L; Boutron I; Ravaud P
    J Clin Epidemiol; 2019 Sep; 113():168-175. PubMed ID: 31153976
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of the CONSORT statement and quality of reports of randomized trials: a comparative before-and-after evaluation.
    Moher D; Jones A; Lepage L;
    JAMA; 2001 Apr; 285(15):1992-5. PubMed ID: 11308436
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reporting randomized, controlled trials of herbal interventions: an elaborated CONSORT statement.
    Gagnier JJ; Boon H; Rochon P; Moher D; Barnes J; Bombardier C;
    Ann Intern Med; 2006 Mar; 144(5):364-7. PubMed ID: 16520478
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Completeness of reporting in abstracts of randomized controlled trials in subscription and open access journals: cross-sectional study.
    Jerčić Martinić-Cezar I; Marušić A
    Trials; 2019 Dec; 20(1):669. PubMed ID: 31791393
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A standard method for reporting ramdomized medical scientific research; the 'Consolidation of the standards of reporting trials' (CONSORT)].
    Ned Tijdschr Geneeskd; 1998 May; 142(19):1089-91. PubMed ID: 9623225
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The CONSORT statement (CONsolidated Standards Of Reporting Trials)].
    Lorette G; Maruani A
    Ann Dermatol Venereol; 2013; 140(6-7):431-5. PubMed ID: 23773740
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Do the CONSORT and STRICTA Checklists Improve the Reporting Quality of Acupuncture and Moxibustion Randomized Controlled Trials Published in Chinese Journals? A Systematic Review and Analysis of Trends.
    Ma B; Chen ZM; Xu JK; Wang YN; Chen KY; Ke FY; Niu JQ; Li L; Huang CB; Zheng JX; Yang JH; Zhu QG; Wang YP
    PLoS One; 2016; 11(1):e0147244. PubMed ID: 26808550
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improving the quality of reporting alcohol outcome studies: effects of the CONSORT statement.
    Ladd BO; McCrady BS; Manuel JK; Campbell W
    Addict Behav; 2010 Jul; 35(7):660-6. PubMed ID: 20207490
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Value of flow diagrams in reports of randomized controlled trials.
    Egger M; Jüni P; Bartlett C;
    JAMA; 2001 Apr; 285(15):1996-9. PubMed ID: 11308437
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials.
    Schulz KF; Altman DG; Moher D;
    Int J Surg; 2011; 9(8):672-7. PubMed ID: 22019563
    [No Abstract]   [Full Text] [Related]  

  • 34. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials.
    Moher D; Schulz KF; Altman DG;
    Clin Oral Investig; 2003 Mar; 7(1):2-7. PubMed ID: 12673431
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials.
    Moher D; Schulz KF; Altman DG
    Lancet; 2001 Apr; 357(9263):1191-4. PubMed ID: 11323066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of the Consolidated Standards of Reporting Trials (CONSORT) checklist on reporting of randomized clinical trials in traditional Chinese medicine.
    Liu XT; Zhang X; Wen S; Peng L; Hong Q; Kang D
    J Evid Based Med; 2015 Nov; 8(4):192-208. PubMed ID: 26334556
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CONSORT 2010 statement: extension to randomised crossover trials.
    Dwan K; Li T; Altman DG; Elbourne D
    BMJ; 2019 Jul; 366():l4378. PubMed ID: 31366597
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reporting number needed to treat and absolute risk reduction in randomized controlled trials.
    Nuovo J; Melnikow J; Chang D
    JAMA; 2002 Jun; 287(21):2813-4. PubMed ID: 12038920
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Better reporting of harms in randomized trials: an extension of the CONSORT statement.
    Ioannidis JP; Evans SJ; Gøtzsche PC; O'Neill RT; Altman DG; Schulz K; Moher D;
    Ann Intern Med; 2004 Nov; 141(10):781-8. PubMed ID: 15545678
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endorsement of the CONSORT guidelines, trial registration, and the quality of reporting randomised controlled trials in leading nursing journals: A cross-sectional analysis.
    Jull A; Aye PS
    Int J Nurs Stud; 2015 Jun; 52(6):1071-9. PubMed ID: 25540865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 83.